Research & Innovation
Projects
The Institut de Recerca Sant Pau develops research projects across multiple scientific areas, with the aim of generating innovative knowledge that has an impact on health. Through national and international collaborations, these projects contribute to scientific progress and the improvement of healthcare.
Finished
PI20/01330
Acúmulo de Proteína Precursora de Amiloide-C99 (APP-C99) como mecanismo de enfermedad en la enfermedad de Alzheimer: implicaciones terapéuticas.
Start Date: 2021-01-01
End Date: 2025-06-30
Amount: 183.920,00 €
Funding body: INSTITUTO DE SALUD CARLOS III
Finished
JLF IULITA POSTDOC FELLOWS
Discovery of novel biomarkers signalling NGF metabollic dysfunction and early AD-dementia in Down sdydrome
Start Date: 2020-01-01
End Date: 2022-09-03
Amount: 154.000,00 €
Funding body: FONDATION JEROME LEJEUNE
Finished
JLF 2020 IULITA
ProNGF and NfL in neuron-derived extracellular vesicles: the gateway to blood biomarker discovery for Alzheimer´s disease prevention in Down syndrome.
Start Date: 2020-07-31
End Date: 2022-08-30
Amount: 39.999,60 €
Funding body: FONDATION JEROME LEJEUNE
Finished
PI21/00063
Estudio traslacional de una predicción de riesgo poligénico y biomarcadores para la detección de la degeneración sináptica en la enfermedad de Alzheimer.
Start Date: 2022-01-01
End Date: 2025-12-31
Amount: 111.320,00 €
Funding body: INSTITUTO DE SALUD CARLOS III
Finished
AACSF-21-850193
Unveiling the impact of biological sex along sporadic and genetic FTLD
Start Date: 2021-11-01
End Date: 2025-10-31
Amount: 6.702,28 €
Funding body: ALZHEIMER'S ASSOCIATION
Finished
AARFD 852492
Evaluation of cortical microinfarcts in individuals with Down syndrome
Start Date: 2022-02-01
End Date: 2025-01-31
Amount: 195,09 €
Funding body: ALZHEIMER'S ASSOCIATION
Finished
AC21_2/00017
Alteraciones preclíncas de sinapsis en enfermedades neurodegenerativas
Start Date: 2022-01-01
End Date: 2025-08-31
Amount: 154.880,00 €
Funding body: INSTITUTO DE SALUD CARLOS III
Finished
2021 SGR 00979
Grup de Recerca en Demències: Sant Pau
Start Date: 2022-01-01
End Date: 2025-06-30
Amount: 40.000,00 €
Funding body: AGÈNCIA DE GESTIÓ D'AJUTS UNIVERSITARIS I DE RECERCA
Finished
SG-23-1014431 iLEADS
Start Date: 2022-09-01
End Date: 2023-08-31
Amount: 0,00 €
Funding body: ALZHEIMER'S ASSOCIATION
Finished
AACSF-22-972945
Molecular bases of bilingualism's protective effect vs cognitive decline
Start Date: 2023-01-01
End Date: 2025-12-31
Amount: 162.210,24 €
Funding body: ALZHEIMER'S ASSOCIATION
Finished
NIH iLeads 5U01AG057195-04
Early Onset AD Consortium - the LEAD Study (LEADS)
Start Date: 2022-10-01
End Date: 2024-05-31
Amount: 92.583,00 €
Funding body: NATIONAL INSTITUTE OF HEALTH
Finished
FUNDELA 2023
Identificación de ARN pequeños en suero como biomarcadores subrogados de los niveles de pTDP43 en el sistema nervioso central
Start Date: 2023-07-28
End Date: 2025-01-31
Amount: 50.000,00 €
Funding body: FUNDACION FUNDELA
Finished
23S06157-001
Urban design for brain and cognitive health: exploring its impact on aging and dementia
Start Date: 2023-11-10
End Date: 2025-09-10
Amount: 35.401,10 €
Funding body: AJUNTAMENT DE BARCELONA
Finished
R33AG066543
TRC_DSN INFRASTRUCTURE
Start Date: 2023-01-01
End Date: 2025-08-31
Amount: 109.391,79 €
Funding body: NATIONAL INSTITUTE OF HEALTH
Finished
IGPCC-B-1264114
Genetically Determined AD: Cross-fertilization between DSAD
Start Date: 2024-01-01
End Date: 2025-05-03
Amount: 22.531,78 €
Funding body: ALZHEIMER'S ASSOCIATION
Finished
#2425_GRT-2024b
#2425_GRT-2024b
Start Date: 2025-01-01
End Date: 2025-07-31
Amount: 0,00 €
Funding body: FONDATION JEROME LEJEUNE
Finished
GINJOL 2024-13-002
A novel therapeutic target for Alzheimer's disease beyond Aβ
Start Date: 2025-01-01
End Date: 2025-12-31
Amount: 10.000,00 €
Funding body: FUNDACIO INSTITUCIO DELS CENTRES DE RECERCA DE CATALUNYA
Finished
2021 SGR 01005
Grup De Senyalització Sinàptica
Start Date: 2022-01-01
End Date: 2025-06-30
Amount: 40.000,00 €
Funding body: AGÈNCIA DE GESTIÓ D'AJUTS UNIVERSITARIS I DE RECERCA
Finished
PI18/01338
Proyecto MAESTRO: Análisis del interactoma: asociación de la MetAgenómica, genómica y Epigenómica con la evolución neurológica y la discapacidad después de un ictuS isquémico.
Start Date: 2019-01-01
End Date: 2022-12-31
Amount: 98.252,00 €
Funding body: INSTITUTO DE SALUD CARLOS III
Finished
AC19/00106
iBioStroke: Identificación y validación clínica de biomarcadores para la evolución clínica post-ictus.
Start Date: 2020-01-01
End Date: 2023-12-31
Amount: 93.170,00 €
Funding body: INSTITUTO DE SALUD CARLOS III